Search - tctmd.com

Displaying 281 - 300 of 309

Sort: Relevancy | Date

Presentation TCT 2012

Promising LAA Closure Devices and the Structural Heart Team Approach

Presenter: Carlos Pedra

October 25, 2012

Presentation TCT 2012

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Presenter: Peter Block

October 23, 2012

Presentation TCT 2012

Synthesis of the New ESC LAA Closure Guidelines

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

Quality-of-Life and Cost-Effectiveness After LAA Closure

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

Lifetech LAA Closure Device: Description and Preclinical Results

Presenter: Yat-Yin Lam

October 23, 2012

Presentation TCT 2012

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

ICE Guidance for LAA Closure: Advantages and Limitations

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

How to Become Trained and Start a LAA Closure Program

Presenter: Brian Whisenant

October 23, 2012

Presentation TCT 2012

Cardia LAA Closure Device: Description and Preclinical Results

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Presenter: Horst Sievert

October 23, 2012

Presentation TCT 2012

Various Techniques for Surgical LAA Closure (With and Without Thoracoscopy): Acute and Long-term Outcomes

Presenter: A. Marc Gillinov

October 23, 2012

Presentation TCT 2012

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

Presenter: David Holmes Jr

October 23, 2012

Presentation TCT 2012

Epicardial LAA Closure with the LARIAT (SentreHEART): Simple, Safe, and Effective?

Presenter: Mark Reisman

October 23, 2012

Presentation TCT 2012

A Primer of LAA Closure Imaging: Essential Views and Pattern Recognition

Presenter: Rebecca Hahn

October 23, 2012

Presentation TCT 2012

Specialized Structural Interventions: Approaches to HOCM, Paravalvular Leak, Acute MI VSD, and LAA Closure

Presenter: Robert Sommer

October 22, 2012

Presentation TCT 2012

LAA Closure Devices

Presenter: Russell Brandwein

October 22, 2012

News Daily News

Un Nuevo Dispositivo Resulta Prometedor para el Cierre Seguro y Eficaz del AAI

Yael L. Maxwell

October 12, 2012

News Daily News

Novel Device Shows Promise for Safe, Effective LAA Closure

Yael L. Maxwell

October 12, 2012

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

September 27, 2012

Advertisement

Promising LAA Closure Devices and the Structural Heart Team Approach

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Synthesis of the New ESC LAA Closure Guidelines

Quality-of-Life and Cost-Effectiveness After LAA Closure

Lifetech LAA Closure Device: Description and Preclinical Results

LAA Closure in Anticoagulation Contraindicated Patients: The ASAP Trial and Beyond

ICE Guidance for LAA Closure: Advantages and Limitations

How to Become Trained and Start a LAA Closure Program

Cardia LAA Closure Device: Description and Preclinical Results

Attributes of the Perfect LAA Closure Device: What All the Companies Should Strive For

Various Techniques for Surgical LAA Closure (With and Without Thoracoscopy): Acute and Long-term Outcomes

The Spectrum of Early Complications of LAA Closure: Have They Been Eliminated?

Epicardial LAA Closure with the LARIAT (SentreHEART): Simple, Safe, and Effective?

A Primer of LAA Closure Imaging: Essential Views and Pattern Recognition

Specialized Structural Interventions: Approaches to HOCM, Paravalvular Leak, Acute MI VSD, and LAA Closure

LAA Closure Devices

Un Nuevo Dispositivo Resulta Prometedor para el Cierre Seguro y Eficaz del AAI

Novel Device Shows Promise for Safe, Effective LAA Closure

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content